MEITAV INVESTMENT HOUSE LTD NRSN NEUROSENSE THERAPEUTICS LTD

Ownership history in MEITAV INVESTMENT HOUSE LTD  ·  13 quarters on record

AI Ownership Summary

MEITAV INVESTMENT HOUSE LTD reported NEUROSENSE THERAPEUTICS LTD (NRSN) in 13 quarterly 13F filings from 2023 Q4 through 2026 Q1. The latest visible filing shows NRSN at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this NRSN ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was MEITAV INVESTMENT HOUSE LTD's position in NEUROSENSE THERAPEUTICS LTD, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

NRSN was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How MEITAV INVESTMENT HOUSE LTD held NRSN — position size vs. price
% of Fund (quarterly)    NRSN price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED 40,000 0% 0.00% $30K 2026-04-29 $0.80
2025 Q4 UNCHANGED 40,000 0% 0.00% $31K 2026-02-10 $1.02
2025 Q3 UNCHANGED 40,000 0% 0.00% $50K 2025-10-29 $1.06
2025 Q2 UNCHANGED 40,000 0% 0.00% $76K 2025-07-23 $2.05
2025 Q1 UNCHANGED 40,000 0% 0.00% $37K 2025-05-12 $1.10
2024 Q4 UNCHANGED 40,000 0% 0.00% $48K 2025-02-03 $1.18
2024 Q3 UNCHANGED 40,000 0% 0.00% $51K 2024-10-28 $1.35
2024 Q2 REDUCED 20.0% +13.4% 40,000 -10,000 -20.0% 0.00% $45K 2024-07-29 $0.77
2024 Q1 REDUCED 47.4% -40.7% 50,000 -45,000 -47.4% 0.00% $91K 2024-05-01 $1.26
2023 Q4 UNCHANGED 95,000 0% 0.00% $75K 2024-01-29 $1.08
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About MEITAV INVESTMENT HOUSE LTD and NRSN

These are the practical questions this page is built to answer before you even open the full history table.

How long has MEITAV INVESTMENT HOUSE LTD reported owning NRSN?

MEITAV INVESTMENT HOUSE LTD reported NRSN across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported NRSN position in MEITAV INVESTMENT HOUSE LTD's portfolio?

The largest reported portfolio weight for NRSN was 0.00% in 2024 Q1.

What is the latest reported NRSN position on this page?

The most recent filing on this page is 2026 Q1, when MEITAV INVESTMENT HOUSE LTD reported 40,000 shares, equal to 0.00% of portfolio, with an estimated market value of $30K.

What does the chart on this NRSN ownership page compare?

The chart compares MEITAV INVESTMENT HOUSE LTD's quarterly NRSN portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did MEITAV INVESTMENT HOUSE LTD time their NRSN position?

Based on 13F filing dates vs. subsequent NRSN price moves, MEITAV INVESTMENT HOUSE LTD correctly timed 1 out of 3 reported position changes (33%). The annualised alpha on NRSN relative to SPY over the holding period was -36.8%.

← Back to MEITAV INVESTMENT HOUSE LTD Holdings